Working group on pharma deals may help harmonize reviews while bringing ‘aggressive’ approach

By Natalie McNelis and Flavia Fortes (March 30, 2021) -- A new transatlantic working group for mergers in the pharmaceutical sector will provide a chance to build on cooperation among regulators to help harmonize analysis, which has sometimes diverged in global deals. The unified process is good news for parties, but it comes with the promise of a more aggressive approach....

Related Sections